Literature DB >> 25374641

Eales disease: no typical clinical presentation.

Belmokhtar Adil1, Daoudi Rajaa1.   

Abstract

Entities:  

Keywords:  Eales disease; retinal phlebitis; visual acuity

Mesh:

Substances:

Year:  2014        PMID: 25374641      PMCID: PMC4218641          DOI: 10.11604/pamj.2014.17.136.4019

Source DB:  PubMed          Journal:  Pan Afr Med J


× No keyword cloud information.

Image in medicine

Eales disease is clinically manifested by retinal phlebitis, the onset of ischemia and retinal vessels neo area is often revealed by vitreous hemorrhage. Its etiology remains unknown. The management of this disease depends on the clinical presentation. Our patient was 27 years old, consults for a progressive loss of visual acuity unilateral in her left eye. On fundus exam at the emergency department, we found a vitreous hemorrhage, retinal hemorrhage, periphlebitis and retinal periphery ischemia (A). Laboratory tests were negative for potentially occlusive vasculopathy. Angiogram shows retinal neovascularization (B) and peripheral ischemic lesions (C, D). The patients received treatment with corticosteroids supplemented by laser photocoagulation. Improved visual acuity was obtained. A) vitreous hemorrhage, retinal hemorrhage, periphlebitis and retinal periphery ischemia; (B, C, D): shows retinal neovascularization and peripheral ischemic lesions
  1 in total

1.  Role of Intravitreal Bevacizumab in Management of Eale's Disease.

Authors:  Mohammad Asim Mehboob; Muhammad Tahir; Huma Batool
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.